Effectiveness versus efficacy trials in COPD: how study design influences outcomes and applicability Source: Eur Respir J, 51 (2) 1701531; 10.1183/13993003.01531-2017 Year: 2018
INTEGRIS-IPF: a 12-week, Phase 2a study evaluating the safety, tolerability and pharmacokinetics of PLN-74809 in participants with IPF Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020
Effects of an internet based tool for self-management in patients with COPD–a controlled pragmatic pilot trial Source: International Congress 2017 – The importance of physical activity in patients with COPD Year: 2017
A randomized, crossover study to examine the pharmacodynamics and safety of a new antimuscarinic (TD-4208) in COPD Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012
Efficacy and safety profile of xanthines in COPD: a network meta-analysis Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018
Efficacy and safety profile of xanthines in COPD: a network meta-analysis Source: Eur Respir Rev, 27 (148) 180010; 10.1183/16000617.0010-2018 Year: 2018
Comprehensive comparison of the repeatability of the most commonly employed tests of exercise performance for patients with stable COPD. An observational study. Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation Year: 2018
Validation of a tool to assess daily active behaviour in COPD patients Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today Year: 2019
Indacaterol dose selection: utilising an adaptive seamless design in a clinical study in COPD Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009
Evaluation of safety, tolerability, pharmacokinetics, and food effect of Danirixin oral tablets in Japanese elderly healthy subjects Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018
A long term randomized clinical study of 300 asthmatics. An internet based asthma monitoring tool improves quality of life significantly Source: Eur Respir J 2004; 24: Suppl. 48, 261s Year: 2004
Biomarker measurement in asthma patients receiving biologic therapy: a real-world retrospective study Source: International Congress 2018 – Eosinophils in airway disease Year: 2018
Effectiveness and acceptability of a smart inhaler asthma self-management programme: a cluster RCT study protocol Source: International Congress 2019 – Innovations in primary care assessment and management Year: 2019
Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design Source: ERJ Open Res, 5 (4) 00061-2019; 10.1183/23120541.00061-2019 Year: 2019
Effectiveness of an individualized action plan on health status recovery in patients with COPD: A randomized controlled trial Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care Year: 2010
A smart mHealth tool versus a paper action plan to support self-management of COPD exacerbations: a randomised controlled trial Source: International Congress 2019 – M-health/e-health I Year: 2019
Indacaterol, a novel β2 -agonist, demonstrates 24-hour efficacy and is well tolerated in patients with asthma: a multiple-dose, dose-ranging study Source: Eur Respir J 2005; 26: Suppl. 49, 253s Year: 2005
Use of inhaler devices in elderly patients with respiratory disease: real-world observational study Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019
Methodological issues in therapeutic trials of COPD Source: Eur Respir J 2008; 31: 927-933 Year: 2008
A realistic study assessing inhaled treatment compliance in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 25s Year: 2001